87 related articles for article (PubMed ID: 16860394)
1. Intraneuronal amyloid beta42 enhanced by heating but counteracted by formic acid.
Ohyagi Y; Tsuruta Y; Motomura K; Miyoshi K; Kikuchi H; Iwaki T; Taniwaki T; Kira J
J Neurosci Methods; 2007 Jan; 159(1):134-8. PubMed ID: 16860394
[TBL] [Abstract][Full Text] [Related]
2. Formic acid is essential for immunohistochemical detection of aggregated intraneuronal Abeta peptides in mouse models of Alzheimer's disease.
Christensen DZ; Bayer TA; Wirths O
Brain Res; 2009 Dec; 1301():116-25. PubMed ID: 19751708
[TBL] [Abstract][Full Text] [Related]
3. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
5. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
[TBL] [Abstract][Full Text] [Related]
6. Aβ42 and Aβ40: similarities and differences.
Qiu T; Liu Q; Chen YX; Zhao YF; Li YM
J Pept Sci; 2015 Jul; 21(7):522-9. PubMed ID: 26018760
[TBL] [Abstract][Full Text] [Related]
7. Coordinated expression of caspase 8, 3 and 7 mRNA in temporal cortex of Alzheimer disease: relationship to formic acid extractable abeta42 levels.
Matsui T; Ramasamy K; Ingelsson M; Fukumoto H; Conrad C; Frosch MP; Irizarry MC; Yuan J; Hyman BT
J Neuropathol Exp Neurol; 2006 May; 65(5):508-15. PubMed ID: 16772874
[TBL] [Abstract][Full Text] [Related]
8. Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease.
Nunomura A; Tamaoki T; Tanaka K; Motohashi N; Nakamura M; Hayashi T; Yamaguchi H; Shimohama S; Lee HG; Zhu X; Smith MA; Perry G
Neurobiol Dis; 2010 Mar; 37(3):731-7. PubMed ID: 20034567
[TBL] [Abstract][Full Text] [Related]
9. Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties.
Sánchez L; Madurga S; Pukala T; Vilaseca M; López-Iglesias C; Robinson CV; Giralt E; Carulla N
J Am Chem Soc; 2011 May; 133(17):6505-8. PubMed ID: 21486030
[TBL] [Abstract][Full Text] [Related]
10. Brain-reactive autoantibodies prevalent in human sera increase intraneuronal amyloid-β(1-42) deposition.
Nagele RG; Clifford PM; Siu G; Levin EC; Acharya NK; Han M; Kosciuk MC; Venkataraman V; Zavareh S; Zarrabi S; Kinsler K; Thaker NG; Nagele EP; Dash J; Wang HY; Levitas A
J Alzheimers Dis; 2011; 25(4):605-22. PubMed ID: 21483091
[TBL] [Abstract][Full Text] [Related]
11. Intraneuronal Abeta42 accumulation in Down syndrome brain.
Mori C; Spooner ET; Wisniewsk KE; Wisniewski TM; Yamaguch H; Saido TC; Tolan DR; Selkoe DJ; Lemere CA
Amyloid; 2002 Jun; 9(2):88-102. PubMed ID: 12440481
[TBL] [Abstract][Full Text] [Related]
12. Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.
Asami-Odaka A; Obayashi-Adachi Y; Matsumoto Y; Takahashi H; Fukumoto H; Horiguchi T; Suzuki N; Shoji M
Neurodegener Dis; 2005; 2(1):36-43. PubMed ID: 16909001
[TBL] [Abstract][Full Text] [Related]
13. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
Chang YJ; Chen YR
FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
[TBL] [Abstract][Full Text] [Related]
14. Analysis of microdissected human neurons by a sensitive ELISA reveals a correlation between elevated intracellular concentrations of Abeta42 and Alzheimer's disease neuropathology.
Hashimoto M; Bogdanovic N; Volkmann I; Aoki M; Winblad B; Tjernberg LO
Acta Neuropathol; 2010 May; 119(5):543-54. PubMed ID: 20198479
[TBL] [Abstract][Full Text] [Related]
15. Wild-type, Flemish, and Dutch amyloid-β exhibit different cytotoxicities depending on Aβ40 to Aβ42 interaction time and concentration ratio.
Shahnawaz M; Sharoar MG; Shin SY; Park IS
J Pept Sci; 2013 Sep; 19(9):545-53. PubMed ID: 23853087
[TBL] [Abstract][Full Text] [Related]
16. Copper inducing Aβ42 rather than Aβ40 nanoscale oligomer formation is the key process for Aβ neurotoxicity.
Jin L; Wu WH; Li QY; Zhao YF; Li YM
Nanoscale; 2011 Nov; 3(11):4746-51. PubMed ID: 21952557
[TBL] [Abstract][Full Text] [Related]
17. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.
Takeda A; Hashimoto M; Mallory M; Sundsumo M; Hansen L; Sisk A; Masliah E
Lab Invest; 1998 Sep; 78(9):1169-77. PubMed ID: 9759660
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein.
Miyamae Y; Kurisu M; Murakami K; Han J; Isoda H; Irie K; Shigemori H
Bioorg Med Chem; 2012 Oct; 20(19):5844-9. PubMed ID: 22921742
[TBL] [Abstract][Full Text] [Related]
19. Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration.
Wegiel J; Kuchna I; Nowicki K; Frackowiak J; Mazur-Kolecka B; Imaki H; Wegiel J; Mehta PD; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Pirttilla T; Frey H; Lehtimäki T; Kivimäki T; Visser FE; Kamphorst W; Potempska A; Bolton D; Currie JR; Miller DL
Acta Neuropathol; 2007 Apr; 113(4):389-402. PubMed ID: 17237937
[TBL] [Abstract][Full Text] [Related]
20. Key residues for the oligomerization of Aβ42 protein in Alzheimer's disease.
Ngo S; Guo Z
Biochem Biophys Res Commun; 2011 Oct; 414(3):512-6. PubMed ID: 21986527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
